Kupatt C - Search Results

1

Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.

Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mikhail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Husser O, Boekstegers P, Hambrecht R, Widder J, Hildick-Smith D, De Carlo M, Wijngaard P, Deliargyris E, Bernstein D, Baber U, Mehran R, Anthopoulos P, Dangas G; BRAVO-3 Investigators. Hengstenberg C, et al. Among authors: kupatt c. Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1027-1037. doi: 10.1002/ccd.27155. Epub 2017 Jun 20. Catheter Cardiovasc Interv. 2017. PMID: 28493641 Clinical Trial.

2

Endothelial activation--a strategic event during postischemic myocardial inflammation.

Kupatt C, Habazettl H, Becker BF, Boekstegers P. Kupatt C, et al. Z Kardiol. 2000;89 Suppl 9:IX/96-100. doi: 10.1007/pl00022844. Z Kardiol. 2000. PMID: 11151805

3

Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion.

Kupatt C, Wichels R, Horstkotte J, Krombach F, Habazettl H, Boekstegers P. Kupatt C, et al. J Leukoc Biol. 2002 Sep;72(3):455-61. J Leukoc Biol. 2002. PMID: 12223512

4

Therapeutic angiogenesis/arteriogenesis in the chronic ischemic rabbit hindlimb: effect of venous basic fibroblast growth factor retroinfusion.

Lebherz C, von Degenfeld G, Karl A, Pfosser A, Raake P, Pachmayr F, Scholz D, Kupatt C, Boekstegers P. Lebherz C, et al. Among authors: kupatt c. Endothelium. 2003;10(4-5):257-65. doi: 10.1080/10623320390246432. Endothelium. 2003. PMID: 14660086

5

Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model.

Kupatt C, Hinkel R, Horstkotte J, Deiss M, von Brühl ML, Bilzer M, Boekstegers P. Kupatt C, et al. Cardiovasc Res. 2004 Feb 15;61(3):530-7. doi: 10.1016/j.cardiores.2003.11.012. Cardiovasc Res. 2004. PMID: 14962483

6

Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study.

Pohl T, Giehrl W, Reichart B, Kupatt C, Raake P, Paul S, Reichenspurner H, Steinbeck G, Boekstegers P. Pohl T, et al. Among authors: kupatt c. Catheter Cardiovasc Interv. 2004 Jul;62(3):323-30. doi: 10.1002/ccd.20060. Catheter Cardiovasc Interv. 2004. PMID: 15224298 Clinical Trial.

7

Current concepts and applications of coronary venous retroinfusion.

Boekstegers P, Kupatt C. Boekstegers P, et al. Among authors: kupatt c. Basic Res Cardiol. 2004 Nov;99(6):373-81. doi: 10.1007/s00395-004-0486-3. Basic Res Cardiol. 2004. PMID: 15503084 Review.

8

Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia.

Pfosser A, Thalgott M, Büttner K, Brouet A, Feron O, Boekstegers P, Kupatt C. Pfosser A, et al. Among authors: kupatt c. Cardiovasc Res. 2005 Feb 15;65(3):728-36. doi: 10.1016/j.cardiores.2004.10.019. Cardiovasc Res. 2005. PMID: 15664400

9

Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy.

Pohl T, Kupatt C, Steinbeck G, Boekstegers P. Pohl T, et al. Among authors: kupatt c. Z Kardiol. 2005 Jun;94(6):405-10. doi: 10.1007/s00392-005-0253-y. Z Kardiol. 2005. PMID: 15940441 Clinical Trial.

10

Embryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin beta4.

Kupatt C, Bock-Marquette I, Boekstegers P. Kupatt C, et al. Trends Cardiovasc Med. 2008 Aug;18(6):205-10. doi: 10.1016/j.tcm.2008.10.002. Trends Cardiovasc Med. 2008. PMID: 19185810 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters